No Data
No Data
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
HC Wainwright & Co. Initiates Coverage On Zenas BioPharma With Buy Rating, Announces Price Target of $30
H.C. Wainwright Initiates Zenas BioPharma(ZBIO.US) With Buy Rating, Announces Target Price $30
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Zenas BioPharma Is Maintained at Overweight by Morgan Stanley
Morgan Stanley Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Cuts Target Price to $35
No Data